greeksoup/ stock research
Stock research / United States / BBIO / Filings

BridgeBio Pharma, Inc. SEC filings

BridgeBio Pharma filed 28 documents with the SEC in the last twelve months, the latest report being the 10-Q of 10 August 2026. The latest filing, on 13 October 2026, was an 8-K: other events.

Filings in twelve months2818 of them 8-K news
Latest report10-Qfiled 10 Aug 2026
Latest filing8-K13 Oct 2026
Last results, two-day move-0.9%results filed 10 Aug 2026
New to this? How to read this page
  1. Companies file with the SEC when something happens. 10-Q and 10-K are the quarterly and annual reports; 8-K is news that cannot wait for the next report.
  2. An 8-K says which items it covers, such as results, a change at the top or a big contract. A foreign company files a 6-K instead.
  3. The results release is usually an 8-K filed the day results come out, before the 10-Q or 10-K.
  4. Every filing links to the original on EDGAR, the SEC's own site.

Twelve months of filings

by kind

Most of the filings were other company news (13). Results came out 5 times.

Each mark is one filing on the day it was filed, in rows by kind. Hover or tap a mark for the form and what it was about.

The share price around each results release

close before to close after

Over the last 5 releases the share price moved 1.6% on average in the two days around results, the most on 12 Jan 2026 (+2.4%).

12 Jan 2026+2.4%$77.25 to $79.11
24 Feb 2026-2.0%$67.91 to $66.54
7 May 2026-1.0%$68.09 to $67.39
10 Aug 2026-0.9%$84.48 to $83.70
Daily closeResults filed

Each ring marks a results filing. The move runs from the last close before the filing to the first close after it, so it covers results released before the open or after the close. Hover the line for any day's close.

What the company told investors on 8-K

18 filings

BridgeBio Pharma's 18 news filings (8-K) were mostly about other events (12) and results of operations (5).

  • Other eventsNews the company chose to file
    12 · latest 13 Oct 2026
  • Results of operationsThe quarterly results release
    5 · latest 10 Aug 2026
  • Material agreementA large contract or deal was signed
    4 · latest 17 Aug 2026
  • Unregistered sale of equityShares sold privately
    2 · latest 2 Jul 2026
  • Regulation FD disclosureMaterial shared with investors, often slides or a presentation
    2 · latest 2 Jul 2026
  • Change to security holders' rightsShareholders' rights changed
    1 · latest 2 Jul 2026
  • Charter or bylaw amendment, or fiscal year changeThe company's rules or fiscal year changed
    1 · latest 2 Jul 2026
  • Officer or director changeSomeone joined, left or changed role at the top
    1 · latest 26 Jun 2026
  • Shareholder voteResults of a vote at a shareholder meeting
    1 · latest 26 Jun 2026
  • Termination of a material agreementA large contract ended
    1 · latest 8 May 2026
  • New financial obligationNew debt or a borrowing
    1 · latest 21 Jan 2026

Each line is one kind of news, with what it means in plain words. Each square is one filing; a filing can carry more than one kind, so the squares can add up to more than the filings. The date opens the latest one on EDGAR.

How it compares

every company on the site

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every filing as a table

    In the last twelve months BridgeBio Pharma, Inc. filed 28 documents with the SEC of the kinds listed here: 18 current reports (8-K), about 12 other events; 5 results of operations; 4 material agreement; 2 unregistered sale of equity; 2 regulation FD disclosure; 3 quarterly reports (10-Q), 2 shelf registrations (S-3ASR), 1 employee share plan registration (S-8), 1 annual report to shareholders (ARS), 1 additional proxy material (DEFA14A), 1 proxy statement (DEF 14A). The latest, filed 13 October 2026: 8-K, other events. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.

    FiledFormWhat it was aboutPeriod or event dateFiling
    13 October 20268-KOther events6 October 2026EDGAR
    31 August 20268-KOther events31 August 2026EDGAR
    17 August 20268-KMaterial agreement, Other events13 August 2026EDGAR
    10 August 202610-Qquarterly report30 June 2026EDGAR
    10 August 20268-KResults of operations10 August 2026EDGAR
    24 July 2026S-3ASRshelf registrationEDGAR
    24 July 2026S-8employee share plan registrationEDGAR
    22 July 20268-KOther events22 July 2026EDGAR
    2 July 20268-KMaterial agreement, Unregistered sale of equity, Change to security holders' rights, Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure1 July 2026EDGAR
    26 June 20268-KOfficer or director change, Shareholder vote22 June 2026EDGAR
    27 May 20268-KOther events27 May 2026EDGAR
    13 May 20268-KOther events12 May 2026EDGAR
    8 May 20268-KMaterial agreement, Termination of a material agreement7 May 2026EDGAR
    8 May 2026S-3ASRshelf registrationEDGAR
    7 May 202610-Qquarterly report31 March 2026EDGAR
    7 May 20268-KResults of operations, Other events6 May 2026EDGAR
    24 April 2026ARSannual report to shareholders31 December 2025EDGAR
    24 April 2026DEFA14Aadditional proxy materialEDGAR
    24 April 2026DEF 14Aproxy statement22 June 2026EDGAR
    30 March 20268-KOther events30 March 2026EDGAR
    24 February 202610-Kannual report31 December 2025EDGAR
    24 February 20268-KResults of operations24 February 2026EDGAR
    12 February 20268-KOther events12 February 2026EDGAR
    21 January 20268-KMaterial agreement, New financial obligation, Unregistered sale of equity, Other events14 January 2026EDGAR
    12 January 20268-KResults of operations, Regulation FD disclosure, Other events12 January 2026EDGAR
    29 October 202510-Qquarterly report30 September 2025EDGAR
    29 October 20258-KResults of operations29 October 2025EDGAR
    29 October 20258-KOther events29 October 2025EDGAR
    An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
    Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.